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It has previously been reported that some strains of the marine bacterium
Pseudoalteromonas luteoviolacea produce the purple bioactive pigment violacein as
well as the antibiotic compound indolmycin, hitherto only found in Streptomyces. The
purpose of the present study was to determine the relative role of each of these
two compounds as antibacterial compounds in P. luteoviolacea S4054. Using Tn10
transposon mutagenesis, a mutant strain that was significantly reduced in violacein
production in mannose-containing substrates was created. Full genome analyses
revealed that the vio-biosynthetic gene cluster was not interrupted by the transposon;
instead the insertion was located to the maeA gene encoding the malic enzyme.
Supernatant of the mutant strain inhibited Vibrio anguillarum and Staphylococcus aureus
in well diffusion assays and in MIC assays at the same level as the wild type strain.
The mutant strain killed V. anguillarum in co-culture experiments as efficiently as the
wild type. Using UHPLC-UV/Vis analyses, we quantified violacein and indolmycin, and
the mutant strain only produced 7–10% the amount of violacein compared to the wild
type strain. In contrast, the amount of indolmycin produced by the mutant strain was
about 300% that of the wild type. Since inhibition of V. anguillarum and S. aureus by
the mutant strain was similar to that of the wild type, it is concluded that violacein
is not the major antibacterial compound in P. luteoviolacea. We furthermore propose
that production of violacein and indolmycin may be metabolically linked and that yet
unidentified antibacterial compound(s) may be play a role in the antibacterial activity of
P. luteoviolacea.
Keywords: Pseudoalteromonas luteoviolacea, indolmycin, violacein, conditional expression, antibacterial activity
Frontiers in Microbiology | www.frontiersin.org 1 September 2016 | Volume 7 | Article 1461
fmicb-07-01461 September 14, 2016 Time: 14:6 # 2
Thøgersen et al. Antibacterial Compounds from Pseudoalteromonas luteoviolacea
INTRODUCTION
The production of bioactive secondary metabolites is an
essential defense mechanism and/or competitive strategy for
many bacterial species. Violacein, a purple bisindole metabolite,
has been extensively studied and has been reported to be
potently antibacterial, antiviral, anti-tumor, antiprotozoal, and
antiparasitic (Balibar and Walsh, 2006; Durán et al., 2007). It is
produced by members of the Beta- and Gamma-proteobacteria,
and has enabled species to occupy new niches. The skin-
dwelling Janthinobacterium lividum, for example, shares a
mutualism with its amphibian host, synthesizing violacein that
provides antifungal protection to its host (Brucker et al., 2008).
In the marine environment, violacein-producing species of
the Pseudoalteromonas genus have been isolated from marine
sponges (Yang et al., 2007), from biofilms on bivalve shells (Gillan
et al., 1998), and from other biotic surfaces such as the alga Ulva
australis (Rao et al., 2007). These niches are typically high in
bacterial density, however, it is not known if or how effective
violacein is in mediating bacteria–bacteria-interactions.
The focus of this study is the purple marine bacterium
Pseudoalteromonas luteoviolacea strain S4054, isolated from
a seawater-immersed surface (Gram et al., 2010). Strains of
P. luteoviolacea are distinctly purple due to the production
of violacein (Gauthier, 1982; McCarthy et al., 1985) and have
also been reported to synthesize an antimicrobial L-amino
acid oxidase (Gómez et al., 2008), as well as the antibiotic
compound pentabromopseudilin (Hanefeld et al., 1994). We
previously detected violacein and pentabromopseudilin in strains
of P. luteoviolacea, and we furthermore identified a non-violacein
compound, indolmycin, from a culture of P. luteoviolacea S4054
where pentabromopseudilin was not detected (Månsson et al.,
2010; Vynne et al., 2012). Both violacein and indolmycin
are based on an indole scaffold, biosynthetically derived from
L-tryptophan (Hurdle et al., 2004; Balibar and Walsh, 2006).
Indolmycin is a secondary metabolite with antibacterial
properties which was first isolated from Streptomyces griseus
(Hornemann et al., 1971). To date, indolmycin biosynthesis
has not been reported in bacteria outside of the phylum
Actinobacteria except for a few strains of P. luteoviolacea
(Månsson et al., 2010; Vynne et al., 2011, 2012). Indolmycin
acts as an antimicrobial compound due to its tryptophanyl-
tRNA synthase inhibition activity (Werner et al., 1976), ceasing
bacterial protein synthesis (Oliva et al., 2003). It is bacteriostatic
against Staphylococcus aureus, and has been tested as a
potential topical agent for use against both methicillin-resistant
and vancomycin-intermediate S. aureus (Hurdle et al., 2004).
However, indolmycin also has a bactericidal effect on Gram
negative Helicobacter pylori (Kanamaru et al., 2001), and it
has therefore been speculated that this compound has different
modes of action on bacteria (Hurdle et al., 2004).
Vynne et al. (2011) clustered four strains of Pseudo-
alteromonas luteoviolacea based on the detection of their
secondary metabolites by HPLC-UV/Vis. Two strains (S4054
with S4047) produced both violacein and indolmycin and
two strains (S4060 with S2607) produced violacein and
pentabromopseudilin (Vynne et al., 2011). Whilst violacein is
difficult to dissolve in water and accumulates in the bacterial
membrane (Konzen et al., 2006), both pentabromopseudilin and
indolmycin are highly water soluble and may each serve the
same role in the four strains. Månsson et al. (2016) analyzed the
metabolome of 13 strains of P. luteoviolacea, and found a large
variety in biochemical potential within each strain (Månsson
et al., 2016). Also, a gene cluster consisting of 12 genes was
identified as the potential indolmycin biosynthetic gene cluster.
This adds to the nine genes identified by Du et al. (2015)
encoding indolmycin in Streptomyces griseus, including two genes
identified as homologues of the quorum sensing genes luxI and
luxR which were not observed in S. griseus (Månsson et al., 2016).
In the present study, we sought to determine the importance
of violacein in the antibacterial activity of P. luteoviolacea S4054.
We initially attempted a targeted gene deletion approach but
were unable to manipulate P. luteoviolacea in this manner and
we therefore used a random mutagenesis approach, creating
a mutant with negligible violacein production. Additionally,
methodology was established to simultaneously quantify
violacein and indolmycin against commercial standards to gain
an accurate insight into the levels of each chemical compound
being produced by P. luteoviolacea S4054 and mutant strains
hereof.
MATERIALS AND METHODS
Bacterial Strains, Media, and Growth
Conditions
Pseudoalteromonas luteoviolacea S4054 was isolated during the
Danish research expedition “Galathea 3” (Gram et al., 2010).
Strain S4054-2 is a spontaneous streptomycin resistant (SmR)
mutant of S4054, which was isolated after overnight incubation
at 25◦C of strain S4054 on Marine Agar (MA; Difco 2216)
supplemented with 200 µg ml−1 streptomycin. Strain S4054-2-
49 is a transposon (Tn) mutant generated from strain S4054-
2, containing a single random insertion of miniTn10:gfp:kan
(Stretton et al., 1998) in its genome. For broth cultures, all
S4054-based strains were grown overnight at 25◦C with shaking
at 200 rpm. The liquid media used were: Marine Broth (MB;
Difco 2216) and marine minimal medium (MMM) (Ostling et al.,
1991) supplemented with 0.3% casamino acids (CAA; Difco
223050) and either 0.4% mannose or 0.4% glucose. Strain S4054-2
was furthermore supplemented with 200 µg ml−1 streptomycin,
and strain S4054-2-49 was supplemented with 200 µg ml−1
streptomycin and 200 µg ml−1 kanamycin. All carbon sources
and chemicals used in this study were obtained from Sigma-
Aldrich (Saint Louis, MO, USA) unless otherwise stated.
Target organisms for antibacterial susceptibility testing
were Vibrio anguillarum 90-11-287 (Skov et al., 1995) and
V. anguillarum NB10 (Milton et al., 1992) grown in MB or
Tryptone Soy Broth (TSB; Oxoid CM129) or on MA or Tryptone
Soy Agar (TSA; Oxoid CM131) and Staphylococcus aureus 8325
(Novick, 1967) grown in Luria Broth (LB) or on Luria Agar (LB
agar) (Oxoid CM996B). All target strains were grown at 25◦C. For
co-cultivation experiments, we used a variant of V. anguillarum
NB10 that was tagged with chloramphenicol resistance (CmR) by
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insertion of plasmid pNQFlaC4-gfp27 (cat, gfp) into an intergenic
region on the chromosome, V. anguillarum NB10 (CmR), kindly
provided by D. Milton, University of Umeå.
Strains used for transposon mutagenesis were
Escherichia coli DH5α(pNJ5000) and E. coli SM10λpir
(pLOF::miniTn10:gfp:kan) (Stretton et al., 1998). E. coli
strains were grown at 37◦C on LB agar or in LB with shaking
at 200 rpm. Streptomycin (200 µg ml−1), kanamycin (200 µg
ml−1), tetracycline (10 µg ml−1), and ampicillin (100 µg ml−1)
were used for selection.
To examine the conditional expression of violacein, Na-
pyruvate and L-Tryptophan was added to the MMM medium
containing CAA and mannose to a final concentration of
11 mg/ml and 1 mg/ml, respectively.
Transposon Mutagenesis and Selection
of Mutants
A violacein-negative mutant of P. luteoviolacea was
created by conjugation with an E. coli donor carrying the
pLOF::miniTn10:gfp:kan plasmid. This plasmid is readily
mobilized from E. coli to P. luteoviolacea but since the
replication of the plasmid is dependent upon a non-conjugative
helper plasmid (pNJ5000), stable kanamycin resistant (KmR)
transconjugants can only be obtained if the miniTn10 transposes
into the host chromosome (Stretton et al., 1998). Selection of
KmR P. luteoviolacea transposon mutants required that the E. coli
donor cells could be selected against. Therefore a spontaneous
SmR derivative of strain S4054 was selected on plates containing
streptomycin. One such mutant, S4054-2 was shown to grow
similar to the parental strain S4054 on marine agar (MA) as well
as in MMM supplemented with casamino acids (CAA).
Triparental conjugation of P. luteoviolacea S4054-2,
E. coli DH5α(pNJ5000), and E. coli SM10λpir
(pLOF::miniTn10:gfp:kan) was performed on a HATF filter
membrane (0.45µm; Merck Millipore Co., Darmstadt, Germany)
placed on MA supplemented with 0.4% glucose. Briefly, all three
strains were grown for 18 h in their corresponding medium
and optimal temperature. Fifty microliters of each strain were
mixed and pipetted onto the HATF membrane. After overnight
incubation at 25◦C, growth on the filter was resuspended in 1 ml
MB and 10× 100µl volumes were plated onto MA supplemented
with streptomycin and kanamycin. After overnight incubation
at 25◦C, 50 colonies that grew were re-streaked onto MA
supplemented with streptomycin and kanamycin. Mutant
strains were selected based on reduced purple pigmentation
as compared to strain S4054-2. Additionally, mutants were
screened for green fluorescent protein (GFP) expression (using
an Olympus BX50 microscope fitted with an epifluorescence
filter; 488 nm excitation, 520 nm emission), indicative of the
insertion of the promoterless gfp transposon in the correct
orientation under the transcriptional control of the promoter of
the interrupted gene.
To confirm the presence of the miniTn10:gfp:kan in strain
S4054-2-49, a 1.3 kb region of the cassette was amplified by PCR
with HotStarTaq DNA polymerase (Qiagen, Venlo, Netherlands),
performed according to the manufacturer’s instructions, using
0.2 µM of each primer kmseq-F and gfpsfiI-F (Stretton et al.,
1998). PCR cycling conditions: 94◦C for 3 min; (94◦C for 30 s,
53◦C for 30 s, 72◦C for 60 s)× 30; 72◦C for 10 min. PCR products
were analysed and visualized by gel electrophoresis using 1% TAE
agarose gels (Promega, Madison, WI, USA).
PacBio Library Preparation and
Sequencing
To determine the site of the Tn insertion in strain S4054-2-49
and to detect other potentially random mutations that might
affect the phenotypes of the mutant strains, P. luteoviolacea
S4054, S4054-2, and S4054-2-49 were whole genome sequenced.
Genomic DNA from the three strains was purified using
the phenol/chloroform/isoamyl alcohol protocol described by
Wilson (2001). SMRTbell R© template library was prepared
according to the instructions from Pacific Biosciences Inc.
(Menlo Park, CA, USA) following the Procedure and Checklist –
20 kb Template Preparation Using BluePippin R© Size-Selection
System. Briefly, for preparation of 15 kb libraries 5 µg genomic
DNA were end-repaired and ligated overnight to hairpin adapters
applying components from the DNA/Polymerase Binding Kit P6
(Pacific Biosciences Inc.). Reactions were carried out according
to the manufacturer’s instructions. BluePippin R© Size-Selection to
10 kb was performed according to the manufacturer’s instructions
(Sage Science, Beverly, MA, USA). Conditions for annealing
of sequencing primers and binding of polymerase to purified
SMRTbell R© template were assessed with the Calculator in RS
Remote (Pacific Biosciences Inc.). SMRT sequencing was carried
out on the PacBio RSII (Pacific Biosciences Inc.) taking one 240-
min movie for each SMRT cell. One SMRT cell per strain was
run. In total, for strain S4054 87,476 reads (mean read length
9,065 bp), for strain S4054-2 74,109 reads (mean read length
9,226 bp), and for strain S4054-2-49 85,558 reads (mean read
length 11,797 bp) were obtained.
Genome Assembly, Error Correction, and
Annotation
Data from each SMRT Cell was assembled independently using
the “RS_HGAP_Assembly.3” protocol included in SMRTPortal
version 2.3.0 using default parameters. Each assembly revealed
two circular chromosomes, but no plasmids. Validity of each
assembly was checked using the “RS_Bridgemapper.1” protocol.
Each replicon was circularized independently, particularly
artificial redundancies at the ends of the contigs were removed
and the two chromosomes were additionally adjusted to dnaA or
tus as the first gene, respectively (Médigue et al., 2005). Finally,
each genome was error-corrected by a mapping of Illumina
reads onto finished genomes using BWA (Li and Durbin,
2009) with subsequent variant calling using VarScan (Koboldt
et al., 2012). A consensus concordance of QV60 could be
confirmed for all of the three genomes. Finally, all genomes were
annotated using Prokka 1.8 (Seemann, 2014) and RAST (Aziz
et al., 2008), and aligned using the genome alignment software
MAUVE 2.4.0 (Darling et al., 2004). Single genes of interest
were translated to amino acid sequences and aligned using CLC
Main Workbench 7.6.4 and used in homology searches using
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blastp (Basic Local Alignment Search Tool1). The genomes have
been deposited in NCBI GenBank under Accession Numbers
CP015411-CP015416.
The genomes were analyzed for putative biosynthetic gene
clusters using AntiSMASH and the ClusterFinder algorithm
(Medema et al., 2011; Weber et al., 2015).
Screening for Antibacterial Activity
The ability of P. luteoviolacea S4054, S4054-2, and S4054-2-
49 to inhibit the growth of a target strain (V. anguillarum
90-11-287 and S. aureus 8325) seeded into agar substrates
was tested as previously described (Hjelm et al., 2004; Gram
et al., 2010). Briefly, the agar substrate contained 1.5% Instant
Ocean (Aquarium Systems Inc., Sarrebourg, France), 0.3% CAA,
0.4% glucose and 1.2% agar (Oxoid Ltd., Hampshire, UK). For
S. aureus, 1% peptone was added. Once cooled to 45◦C and
prior to pouring, 10 µl of target strain, which had been grown
stagnant overnight at 25◦C in its corresponding rich medium,
was added to 20 ml agar substrate. For well diffusion agar assay,
5 mm diameter wells were punched into the agar surface and
50 µl of filter sterilized (0.2 µm filter; Merck Millipore Co.)
culture supernatant was loaded into each well. The supernatants
were produced by centrifugation and serial dilution of 24,
48, and 72 h cultures grown in MMM CAA mannose. After
incubation, inhibition zones of the same size were identified
for all three strains. Following 24 h incubation at 25◦C, the
diameter of the clearing zone produced due to inhibition of
growth of the target strains from edge to edge of the zone,
including the well, was measured. Each sample was tested in
duplicate.
For minimum inhibition concentration (MIC) assay, target
strains V. anguillarum 90-11-287 and S. aureus 8325 were
cultured in MB and LB, respectively, and incubated stagnant
at 25◦C overnight. Strains S4054, S4054-2, and S4054-2-49
were cultured for 72 h at 25◦C in MMM CAA mannose
(no antibiotics), supernatants were sterile filtered (0.2 µm
filters; Merck Millipore Co.), and tested in twofold dilutions
in 100 µl target strain diluted to OD600 0.01 in microtiter
plates. Plates were incubated at 25◦C overnight against
V. anguillarum 90-11-287 and for 48 h against S. aureus 8325.
All MICs were carried out with four replicates and repeated
twice.
Vibrio anguillarum Competition
Experiments
Vibrio anguillarum NB10 (CmR) was co-inoculated together
with cultures of the P. luteoviolacea strains in MMM CAA
mannose. All cultures were grown in a 50 ml volume of
medium in a 250 ml Erlenmeyer flask in duplicate. Cultures
of V. anguillarum NB10 (CmR) and S4054, S4054-2 or S4054-
2-49 were grown separately overnight in TSB (NB10, CmR)
and MMM CAA mannose (S4054 strains) and added to MMM
CAA mannose to concentrations of 103 (NB10, CmR) and
106 (S4054 strains) cells ml−1, respectively. Simultaneously, a
MMM CAA mannose control culture was inoculated with 103
1http://blast.ncbi.nlm.nih.gov/Blast.cgi
CFU ml−1 V. anguillarum NB10 (CmR). Samples were taken at
regular intervals (0, 3, 6, 9, 12, and 24 h) and cell density was
determined by dilution and surface plating. Vibrio anguillarum
NB10 (CmR) from the competition experiment was counted
on TSA plates with 4 µg ml−1 chloramphinicol incubated
overnight at 30◦C, since S4054 did not grow on TSA with
chloramphenicol nor at 30◦C. Strains S4054-2 and S4054-2-
49 were selected for on MA with streptomycin and incubated
at 25◦C, since V. anguillarum NB10 (CmR) is streptomycin-
sensitive.
Quantification of Violacein and
Indolmycin
Extraction of violacein and indolmycin for quantitative studies
was tested using propan-2-ol, methanol, ethanol, and acetonitrile.
Acetonitrile created a two-phase system of variable size due
to the media salts and could not be used. Methanol and
ethanol had to be added at 5 and 2 times the sample
volume, respectively, to extract the violacein quantitatively.
This resulted in a lower concentration of the analytes in
the mixture and also a need to inject more of the mixture
to maintain a reasonable UHPLC (Ultra High-Performance
Liquid Chromatography) peak shape for di-demethylindolmycin.
Overall, propan-2-ol provided the most accurate extraction, so
5 ml of bacterial culture (fresh or thawed from −20◦C storage)
were prepared for the quantification of violacein, indolmycin, and
indolmycin precursors by the addition of an equal volume of
propan-2-ol.
The mixture was inverted until homogeneous and placed
in an ultrasonication bath for 30 min. Tubes were centrifuged
(4,000 × g, 15 min) to pellet the biomass (colorless) from
the extracted violacein, indolmycin and related compounds in
solution. Seven hundred and fifty microlitres of supernatant was
transferred to an autosampler vial. UHPLC-UV/Vis analysis was
performed on a Dionex RSLC Ultimate 3000 system (Sunnyvale,
CA, USA) using a 150 mm × 2 mm i.d., 2.6 µm Kinetex C18
column (Phenomenex, Torrance, CA, USA), running at 800 µl
min−1 and 60◦C using a binary linear solvent system of water (A)
and acetonitrile (B) (both buffered with 50 µl l−1 trifluoroacetic
acid; TFA). The gradient program was: t = 0, 15% B; t = 0.5 min
25% B; t = 6 min 65% B; and t = 7 100% B, keeping this for
1 min, then reverting to 15% in 1 min. A sample volume of 1.5 µl
was injected.
Violacein (RT 2.76 min) was detected recording absorption at
578± 2 nm, and indolmycin (1.98 min), di-demethylindolmycin
(RT 1.21 min), and the two mono-demethylindolmycin (1.60
and 1.64 min, integrated as one peak) by absorption at
219± 2 nm.
Quantification by external standard calibration using
six different concentrations of violacein and indolmycin
for the calibration (40, 20, 10, 5, 2, and 1 µM) resulted in
a linear calibration curve with R2 of 0.9999 and 0.9997,
respectively. Extraction efficiency was tested by extracting
various batches of samples three consecutive times, showing
an extraction efficiency of >97%. The di- and mono-
demethylindolmycins were quantified using the indolmycin
calibration curve, since these compounds have the same
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chromophore and thus molar extinction coefficient. Detection
limits were 1 µM for violacein, and 10, 5, and 1 µM for
di-demethylindolmycin, mono-demethylindolmycin, and
indolmycin, respectively.
Identification of Indolmycin-Related
Compounds
Samples for HPLC-UV/MS analyses were prepared from 30 ml
cultures in MB and MMM CAA glucose or mannose. The
culture broth was extracted with Diaion HP20 (Sigma–Aldrich,
St. Louis, MO, USA), which was subsequently filtered off and
extracted with MeOH, while the pellet was extracted using
ethyl acetate (EtOAc). Extracts of pellet and broth were pooled,
filtered, and evaporated under N2 until dry. Samples were re-
dissolved in methanol (MeOH) and transferred to autosampler
vials for HPLC-UV/MS analysis. HPLC-UV/MS samples were
analyzed using an Agilent 1100 HPLC system with a diode array
detector (Agilent Technologies, Waldbronn, Germany) coupled
to an LCT TOF mass spectrometer (Micromass, Manchester, UK)
using a Z-spray ESI source. A Phenomenex Luna II C18 column
(50 mm × 2 mm, 3 µm) was used for separation, applying an
acetonitrile-water (20 mM formic acid) 0.3 ml min−1 gradient
(15–100%) over 20 min at 40◦C.
Indolmycin (2.1 mg) and di-demethylindolmycin (1.7 mg)
were isolated from a 1 l culture of S4054-2-49 in MMM CAA
mannose by EtOAc extraction (2 × 500 ml). The EtOAc phase
was dried with Na2SO4, filtered, and evaporated until dry.
The crude extract was separated using a Luna II C18 column
(250 × 10 mm, 5 µm; Phenomenex) on a Gilson 322 liquid
chromatograph with a 215 liquid handler (BioLab, Risskov,
Denmark), with an automatic fraction collector, applying a
gradient from 20 to 100% acetonitrile in water (buffered with
50 ppm TFA) over 20 min (5 ml min−1).
NMR spectra were recorded on a Varian Unity Inova 500 MHz
spectrometer (Agilent) equipped with a 4 mm gHX Nano probe
and with a spin rate of 2 kHz for all samples, using standard pulse
sequences. The signals of the residual solvent protons and solvent
carbons were used as internal references (δH 3.3 and δC 49.3 ppm
for methanol-d4).
Statistical Analyses
A two-sample two-tailed t-test (Zar, 1996) was used to compare
the difference between two means of log transformed CFU ml−1
or concentrations of secondary metabolites.
RESULTS
Selection of Mutants with Impaired
Violacein Production from a miniTn10
Transposon Library of P. luteoviolacea
S4054-2
Violacein producing bacteria are easily detected by their deep
violet color. Initially, we attempted to construct a deletion mutant
in either of the vio-genes, but all attempts on site-directed
mutagenesis failed. Instead, a random transposon insertion
library of mutants was constructed to select for violacein-negative
mutants of the violacein producing, SmR P. luteoviolacea strain
S4054-2. The SmR mutant used for conjugation behaved similarly
to the wild type in growth and well diffusion agar assays. Whole
genome sequencing revealed that the Sm resistance could be
attributed to two single nucleotide polymorphisms (SNPs), both
of which lead to non-synonymous amino acid exchange: One
occurred in the rpsL gene which encodes the 30S ribosomal
protein S12 and the other in the rsmG gene encoding the
ribosomal RNA small subunit methyltransferase G (Table 1).
Mutations in these two genes are known to confer streptomycin
resistance in, e.g., E. coli, Campylobacter coli, and Mycobacterium
spp. (Timms et al., 1992; Springer et al., 2001; Olkkola et al., 2010)
and lead to antibiotic overproduction in Streptomyces coelicolor
and several species of Actinomycetes (Nishimura et al., 2007;
Tanaka et al., 2009). Therefore, we deduce that the acquired
streptomycin resistance in strain S4054-2 is a result of either of
these two mutations.
TABLE 1 | Mutations in P. luteoviolacea S4054 resulting in SmR strain S4054-2 and the maeA mutant S4054-2-49 based on WGS.
Strains Type of mutation Annotation of affected
gene
Functional role Effect of mutation
S4054 to S4054-2 A to G (aa: C to R, pos. 237) mreB, Rod-shape
determining protein MreB
Formation of the rod shape of
cells
No phenotypic effect
G to A (aa: P to S, pos. 91) rpsL, 30S ribosomal protein
S12
Confers streptomycin
resistance in E. coli, high level
Streptomycin resistance
C to T (aa: G to R, pos. 78) rsmG, Ribosomal RNA small
subunit methyltransferase G
Confers streptomycin
resistance and antibiotic
overproduction in
Actinomycetes and
Streptomycetes, low level
Streptomycin resistance
and possibly indolmycin
overproduction
S4054-2 to S4054-2-49 Insertion of Tn cassette maeA, NAD-dependent malic
enzyme
Conversion of malate to
pyruvate
Interruption of maeA
Insertion of 1 bp tonB, Transport protein TonB Cross-membrane uptake of
specific substrates
Interruption of tonB
Further mutations appeared from the genome alignments, but could either be attributed to sequencing errors or occurred in regions that could not be annotated. Tn
cassette, transposon cassette; aa, amino acid; pos., refers to the amino acid position in the annotated protein sequence.
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Transposon mutagenesis of S4054-2 with E. coli
DH5α/pLOF::miniTn10:gfp:kan resulted in a library of SmR
and KmR resistant S4054-2 genX::miniTn10:gfp:kan mutants,
most of which were pigmented. Despite many repeated attempts
only 50 mutants grew and one mutant S4054-2-49 showed a non-
pigmented phenotype on MA plates containing streptomycin
and kanamycin. PCR amplification of the gfp-kan junction in
S4054-2-49 confirmed the presence of the miniTn10:gfp:kan
and epifluorescence microscopy showed that the mutant, in
contrast to S4054 and S4054-2, produced Gfp. Whole genome
sequencing of S4054-2-49 showed that the miniTn10 cassette had
inserted into the maeA gene encoding a NAD-dependent malic
enzyme that converts malate to pyruvate and CO2. The insertion
sequence was located between the N-terminal domain and the
NAD-binding domain of maeA, interrupting the production of a
functional malic enzyme (Figure 1).
Conditional Production of Violacein
Pigmentation by the S4054-2 maeA
Mutant
Selection of the maeA mutant was performed on solid MA
medium, which contains sources of amino acids and vitamins
(from peptone and yeast extract) as well as all required salts for
S4054 to grow on. As detected during the selection of S4054-
2-49 maeA, it showed a non-pigmented beige phenotype when
grown on MA. After re-streaking the mutant, however, it was
found that the colonies became purple after 2 days of growth at
room temperature. This showed that the absence of the malic
enzyme did not prevent the formation of violacein altogether,
but rather delayed the production or redirected the metabolism
away from violacein synthesis. Therefore we screened the mutant
in a number of culturing conditions for the production of
violacein pigment. The two parental strains, S4054 and S4054-
2 (SmR), produced pigments under all conditions tested, but
the maeA mutant failed to produce pigment in tubes containing
liquid MMM medium supplemented with CAA and mannose.
Interestingly, growth on MMM agar plates resulted in fully
pigmented S4054-2-49 maeA colonies, which showed that either
the mutant required high oxygen tension for violacein synthesis
(provided on plates), or that the agar substrate provided a
required compound for biosynthesis. Since violacein is derived
from the amino acid tryptophan, the effect of L-tryptophan
addition to liquid MA was tested. Addition of Na-pyruvate was
also tested because the absence of the malic enzyme in the
mutant could lower the pyruvate production. Tryptophan did
not promote purple pigmentation, but instead resulted in a more
yellowish tint. Addition of pyruvate or pyruvate + tryptophan
also resulted in beige and yellowish cultures, with no visible trace
of purple color.
Quantification of Violacein and
Indolmycin in Wild Type and maeA
Mutant
To obtain more quantitative evidence for the conditional
production of violacein, we performed chemical analysis of 2-
propanol extracts from culture samples after growth of S4054,
S4054-2, and S4054-2-49 maeA mutant in liquid MMM CAA
mannose medium. The maeA mutant was indeed deficient in
violacein production as compared to the wild type (Table 2).
The violacein concentration remained around 4 µM during
72 h of incubation in MMM CAA mannose, while the violacein
concentration increased to 54 µM in the wild type culture, and to
80 µM in the S4054-2 SmR derivative.
During analysis of the mutant strains, a series of strong
peaks was identified all of which were much higher than in the
extracts from the wild type (Figure 2). The UHPLC-UV/MS
profile of the Tn mutant S4054-2-49 maeA culture extract
from MMM CAA mannose (Figure 2C) showed the expected
TABLE 2 | Antibacterial activity and mean violacein and indolmycin
concentration (± standard error) produced by P. luteoviolacea S4054 and
mutant strains in MMM CAA mannose.
Strain Time (h) Zone size of inhibition
(mm)∗
Violacein
(µM)∗
Indolmycin
(µM)∗
V. anguillarum S. aureus
S4054 24 23 28 43 ± 9 36 ± 2
48 27 35 50 ± 6 46 ± 2
72 28 31 54 ± 9 56 ± 2
S4054-2 24 19 26 74 ± 17 21 ± 1
48 26 31 74 ± 10 28 ± 3
72 26 32 83 ± 13 44 ± 2
S4054-2-49 24 20 26 4.1 ± 0.1 107 ± 3
48 23 29 3.8± 0.05 141 ± 0.3
72 26 31 4.0 ± 0.1 165 ± 0.7
Sampling time (h; indicative of hours post-inoculation of the culture) is indicated.
∗n = 2.
FIGURE 1 | Genetic arrangement of the Tn10 insertion in the chromosome of P. luteoviolacea S4054-2. The Tn10 cassette is located between the
N-terminal domain (maeA_1) and the NAD-binding domain (maeA_2) of the NAD-dependent malic enzyme encoding gene maeA.
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FIGURE 2 | HPLC-UV profiles of 72 h cultures grown in MMM CAA
mannose. (A) wild type strain S4054, (B) streptomycin resistant mutant strain
S4054-2, (C) transposon mutant strain S4054-2-49. The identity of the peaks
were determined by LC-HRMS: (1) N,C-didemethyl-indolmycin, (2/3)
mono-N/C-demethyl-indolmycin, (4) indolmycenic acid, (5) indolmycin, and (6)
violacein.
peak for violacein (labeled 6 in Figure 2C) together with a
series of compounds which could be identified as derivatives of
indolmycin: di-demethylindolmycin (labeled 1 in Figure 2C),
mono-N/C-demethylindolmycin (labeled 2 and 3), indolmycenic
acid (labeled 4) (Hornemann et al., 1971), and indolmycin
(labeled 5) (Speedie et al., 1975). Structures were validated by
NMR for compounds 1, 5, and 6 (Månsson et al., 2010), while
the remaining compounds were tentatively identified based on
their retention time, accurate mass and the deduced molecular
formulas together with their UV/Vis characteristics (Figure 3).
Strains S4054 and S4054-2 produced the same compounds, but
the ratios between the individual compounds were very different
in all three strains (Figures 2A,B). Precise quantification showed
that the concentration of indolmycin increased for both wild
type and mutant strains, but that the final concentration in the
maeA mutant was elevated 3.8-fold when compared to the level
in the parental strain S4054-2. A stoichiometric calculation shows
that the molar increase in indolmycin production is roughly 1.5-
fold higher than the decrease in violacein production (1.2, 1.6,
and 1.5, for 24, 48, and 72 h of growth, respectively), suggesting
that the metabolism could have been rerouted in the maeA
mutant.
Antibacterial Activity of Culture
Supernatants from Wild Type and maeA
Mutant
To test for the antibiotic activity of the three P. luteoviolacea
strains, cell free extracts were produced to assay their inhibitory
effect on the growth of Vibrio anguillarum and Staphylococcus
aureus. Zones of 26-28 mm were found for V. anguillarum
from 72 h-cultures while 31–32 mm inhibition zones were
found for S. aureus (Table 2). Thus, the difference in violacein
concentration in the cultures was not reflected in the size of
the inhibition zones. MIC assays confirmed that the culture
supernatants had identical levels of antibacterial activity with
minimal inhibitory concentration at 32-fold and 128-fold
dilutions against V. anguillarum and S. aureus, respectively (data
not shown).
FIGURE 3 | Chemical structures of (1) N,C-didemethyl-indolmycin, (2/3) mono-N/C-demethyl-indolmycin, (4) indolmycenic acid, (5) indolmycin, and
(6) violacein.
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FIGURE 4 | Co-cultivation of P. luteoviolacea strains with Vibrio anguillarum NB10 (CmR). Colony forming units (CFU/ml) of V. anguillarum NB10 (CmR)
(open symbols) after co-cultivation with S4054 wt (violacein, indolmycin), S4054-2 (violacein, indolmycin) or S4054-2-49 (violacein, indolmycin) as well as CFU/ ml of
P. luteoviolacea S4054, S4054-2 or S4054-2-49 (black symbol) after co-cultivation with V. anguillarum NB10 (CmR) from 0 to 24 h. Vibrio anguillarum NB10 (CmR)
control culture CFU/ml was also recorded during growth over 24 h.
Inhibition of Vibrio anguillarum by
Co-culturing with P. luteoviolacea Wild
Type and Mutant Strains
When V. anguillarum NB10 (CmR) was inoculated with S4054,
S4054-2, or S4054-2 maeA in MMM CAA mannose at a
ratio of approximately 1:1000 (103 and 106 cells ml−1 for
V. anguillarum and P. luteoviolacea, respectively) the Vibrio
strain was outcompeted after 25 h of growth (Figure 4). When
V. anguillarum was grown alone, it showed a short exponential
growth phase after a lag phase of 3 h, and grew to a cell density of
almost 107 CFU ml−1. Each of the three P. luteoviolacea strains
had a similar growth pattern and grew to approximately 109 CFU
ml−1 by 24 h (Figure 4). In co-cultures with Pseudoalteromonas,
the V. anguillarum strains initially grew as in monocultures,
but after 6 h where the P. luteoviolacea stains had grown to
approximately 107 CFU ml−1, the number of colony forming
V. anguillarum cells started to level off. After 12 h where
P. luteoviolacea entered stationary phase, most V. anguillarum
cells had died, or were unable to form colonies. The bactericidal
effect observed was not dependent on the production of violacein
as there was no significant difference in V. anguillarum NB10
(CmR) cell numbers when grown together with S4054 (P > 0.05)
or S4054-2-49 (P > 0.05).
DISCUSSION
Pseudoalteromonas luteoviolacea strain S4054 produces both
violacein and indolmycin (Månsson et al., 2010). To the best
of our knowledge, this is the only reported bacterial species
that produce both violacein and indolmycin, leading us to
investigate whether the synthesis of the two L-tryptophan
derived bioactive compounds were interconnected. Transposon
mutagenesis resulted in the isolation of a beige maeA::miniTn10
mutant strain that exhibited a combination of reduced violacein
and increased indolmycin production (Table 2). Culture
supernatants from the maeA mutant, grown for 72 h, contained
less than 10% of the violacein level present in culture
FIGURE 5 | Malic enzyme MaeA is catalyzing the conversion of malate
into pyruvate, which is subsequently used for the production of
tryptophan used for violacein and indolmycin biosynthesis.
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supernatants from the wild type strain S4054 (Table 2).
Konzen et al. (2006) proposed that violacein is located in
the cell membrane of C. violaceum to protect the bacterial
cell from oxidative stress. This function correlate well with
our finding that violacein was only produced in the maeA
mutant under high oxygen tensions. It is possible that the
beige phenotype originating from the decreased violacein
production in the mutant made it possible to detect stress
induction of violacein genes by their pigmentation, while this
induction would normally be hidden by the un-induced violacein
production.
The malic enzyme, encoded by the maeA gene, catalyzes
the conversion of malate into pyruvate and CO2 (Kwon et al.,
2007). When P. luteoviolacea grows on substrates that enter
through the citric acid (TCA) cycle, its obligate respiratory energy
metabolism is dependent upon replenishing reactions that can
provide acetyl-CoA for the continuation of the cycle (Figure 5).
According to the KEGG database (Kanehisa and Goto, 2000;
Kanehisa et al., 2016), four enzymes are able to provide this
function in Pseudoalteromonas species (data not shown): The
malic enzymes MaeA and MaeB require NAD+ or NADP+ for
reduction of malate to pyruvate and CO2, respectively, while
the phosphoenolpyruvate (PEP) carboxykinase (Pck) and the
oxaloacetate decarboxylase (OadABC) are not redox enzymes.
The replenishing enzymes are also needed for fueling the
gluconeogenesis reactions needed for synthesis of amino acids,
nucleotides, lipids, etc. Tryptophan synthesis which is needed
for synthesis of both violacein and indolmycin is likely to be
affected by the replenishment reactions as two molecules of
PEP are consumed for every tryptophan molecule formed, in
the AroH and AroA reactions, respectively (Kedar et al., 2007).
Disruption of the maeA gene would prevent the use of NAD+
to replenish pyruvate from malate and the mutant would rely
on the remaining three reactions. Furthermore, the conversion
of malate into pyruvate is the least thermodynamically favored
reaction, but is the one that occurs in nature since the kinetic
parameters of the malic enzyme have evolved to favor this
direction (Murai et al., 1971; Stols and Donnelly, 1997). However,
the opposite direction is actually thermodynamically favored
(Goldberg et al., 1993), so with the MaeA encoding gene knocked
out, pyruvate is converted into malate without the opposite
reaction occurring. Violacein synthesis requires two molecules
of tryptophan while indolmycin synthesis requires only one.
Therefore the shift from violacein to indolmycin production
would suggest that the maeA mutation had resulted in decreased
tryptophan or PEP production. This appears highly illogical, so
our hypothesis is that the conditional production of violacein in
the maeA mutant is due to regulatory mechanisms controlling
the replenishing reactions. Availability of redox co-enzymes, e.g.,
regeneration of NAD+ in the respiratory chain, could also be
important, as efficient aeration has been shown to be important
for violacein production (Yang et al., 2007). At present the
knowledge about these systems in Pseudoalteromonas species is
too limited to make any conclusions about the exact nature of the
cause.
With regard to their antimicrobial activity, culture
supernatants from either wild type or maeA mutant inhibited
the growth of Gram positive S. aureus and Gram negative
V. anguillarum equally well (Table 2) in spite of the reduced
violacein content in the maeA mutant. Since neither violacein
nor indolmycin concentration correlated with the size of
the inhibition zone, and since violacein is located in the cell
membrane and therefore would not be present in our cell-free
supernatants, we suggest that a yet unidentified compound could
be responsible for the major part of the antimicrobial activity.
This hypothesis is supported by the fact that the genome of
P. luteoviolacea S4054 contains several putative biosynthetic
gene clusters, most of which have not yet been assigned a specific
function (Machado et al., 2015; Månsson et al., 2016). Out
of a total of 36 putative antibiotic and secondary metabolite
gene clusters determined by AntiSMASH (Medema et al., 2011;
Weber et al., 2015), nine can be attributed a specific function,
and a further nine can be attributed a hypothetical function,
including production of indolmycin, and the remaining 18
can only be classified on a putative type of gene cluster level,
primarily identified by the ClusterFinder algorithm (Weber et al.,
2015)
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